Express Healthcare
Home  »  News  »  ICMR releases data on incidence rate of prostate cancer in India

ICMR releases data on incidence rate of prostate cancer in India

0 1,015
Read Article

The incidence rate of prostate cancer is 9-10/100000 population, higher compared to countries like Asia, Africa, lower compared to US, Europe

In observance of Prostate Cancer Awareness month i.e September, Indian Council of Medical Research (ICMR) has released data on the incidence rate of prostate cancer in India. It states that the incidence rate of prostate cancer is 9-10/100000 population, higher compared to countries like Asia and Africa, but lower compared to the US and Europe. Hence, experts suggest going for complete physical examination including DRE in order to detect prostate cancer at an early stage.

Prostate cancer affects the prostate gland which is situated distal to the bladder neck. It is commonly seen in men above the age of 60. Typically, the symptoms are a frequent urge to urinate, painful urination, repeated urinary tract infections (UTI) and occasionally blood in the urine. Surgical treatment includes open surgery (open radical prostatectomy) that is the surgical removal of the prostate gland or minimal invasive surgery (MIS)- robot-assisted radical prostatectomy (RALP). The additional benefits of the later are precision surgery, less blood loss and reduced pain with a short hospital stay and early return to work.

Dr Jagdeesh Kulkarni, Prof of Uro-oncology, Asian Cancer Institute, said, “People above the age of 60 are at an increased risk of suffering from prostate cancer. One of the best ways for early detection of prostate cancer is DRE and the prostate-specific antigen (PSA) blood test. Those people who have a family history of prostate cancer, irrespective of the symptoms should undergo regular check-ups including DRE and PSA, after the age of 45.”

“Furthermore, it is recommended to embrace a healthy lifestyle, cessation of smoking, well-balanced diet and regular physical exercises would go a long way in keeping prostate cancer at bay,” concluded Dr Kulkarni.

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
close-image
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More
close-image